8-9 May 2024, Dubai World Trade Centre

Over US$1 billion in funds available to healthcare innovators at EMERGE 2050

OVER $1 BILLION IN FUNDS AVAILABLE TO HEALTH TECH INNOVATORS AT EMERGE 2050

1000+

Professional visits

24

Healthtech, medtech & biotech startups

4

Pavilions

80%

C-suite attendees

Featured investors at emerge 2050

ACCELERATING HEALTHCARE IN THE MENA REGION

EMERGE 2050 is dedicated to innovations in healthtech, medtech and biotech, providing disruptors in start-up and growth stage, the chance to meet investors.

As well as being able to pitch the venture capitalists, our disruptors have the opportunity to speak in the event’s main stage program, to address healthcare providers and payers, and to talk about the role they see their ideas taking in cost saving and greater efficiency in the sector.

The event takes place alongside PrecisionMed Exhibition & Summit on 8 – 9 May 2024 in Sheikh Rashid Hall at the Dubai World Trade Centre.

This year we have introduced “The Nest”, a dedicated area for innovators to display products and pitch their concepts to the cross section of stakeholders in attendance.

Featured innovators and partners At emerge 2050

WHY SHOULD YOU ATTEND?

As an Innovator

Revel in a setting with a high concentration of capital. Investors with a combined value of US$1+ billion in funds will be onsite to meet companies like yours. Pitch your idea. Meet with the teams behind the money. Find the capital and partnering to take your idea forward.

*Limited number of positions available. Apply today.

as an Investor

A multitude of early stage and growth stage innovators present and in circulation. Rub shoulders with peers and associates in life science investment. Whether or not you are already engaged and doing business in the Middle East, this is a superb opportunity to network and tap into emerging opportunities. Engage multiple stakeholders, find new innovation, establish investment for future funds.

payers & healthcare providers

Under the theme “Taking the cost out of healthcare”, key marketplace professionals will take the stage to discuss what’s next. Speakers include a broad eco system of actors including government regulators, payers and insurers, investors, innovators, CFOs and heads of business and specialist media leaders.

Key speakers

Edward Kliphuis

Partner,
Sofinnova Partners

Dr. Sarper Tanli

Managing Director, MEA; Global Advisory, Mass General Brigham

Pilar Fernandez Hermida

Founder,
i-Expand

Ashraf Bacheet

CEO & Co-Founder,
O7 Therapy

Sophie Smith

Founder and CEO,
Nabta Health

Vikash Sharma

Group CEO,
Avisa Smart Hospitals

Reenita Das

Partner,
Frost & Sullivan

Hossein Fakhrai-Rad

Founder,
Healthasion

Arnoud Huisman

CEO and Chairman of the Board,
Oncode Accelerator

Ayman Semaan

Market Access & Pricing Lead,
Biologix

Kareem Barghouti

Co-Founder & CEO,
PragmaBio

Desiree Cox

CEO and Founder,
The HEALinc

who will be ATTENDINg emerge 2050

Healthtech, medtech & biotech startups
37%
Investors
24%
Leaders from the healthcare industry
23%
Insurers and pharmaceutical delegates
10%
Medical professionals
6%

WHY VISIT EMERGE 2050?

  • Free to attend, two day conference programme
  • “The Nest” exhibition and networking area

  • Visitor access to PrecisionMed Exhibition & Summit
  • Key networking opportunities with tech innovators, investors, payers and insurers

“This show is absolutely amazing”

Jeffrey Stephens, Chief Investment Officer, Infusion 51a LP

Co-located with PrecisionMed Exhibition & Summit 2024

The 3rd edition of PrecisionMed Exhibition & Summit (PMES) takes place in May 2024. PMES aims to welcome over 7,000 healthcare professionals including doctors, disease specialists, laboratory heads, researchers, as well as senior roles from reseller and distributor organisations, government, innovators and investors, and others interested in the latest development in personalised care.

Find out more.

Join us in driving healthcare innovation and investment

Get in touch:

For sales/sponsorship enquiries:

e: sales@precisionmedexpo.com
m: +971 52 684 5560

Co-located with:

“This show is absolutely amazing”

Jeffrey Stephens, Chief Investment Officer, Infusion 51a LP